A high-class team of scientists at Mestag Therapeutics, based at Chesterford Research Park, is developing therapeutics targeting activated fibroblast populations across these disease areas.
Newborn bio business Mestag Therapeutics raises $11m seed cash
27 April 2021
A new Cambridge UK BioMedTech business fighting inflammatory disease and cancer has launched with $11 million seed cash from healthcare backers SV Health Investors and Johnson & Johnson Innovation.